EGFR and bone neoplasm: In line with this study, we found significantly elevated tumor formation and progression when we boosted EGFR signaling in bone tumors by crossing H2‐c‐fosLTR mice to mice that overexpress AREG under an osteoblast‐specific promoter (ColAREG), suggesting that AREG could indeed be a clinically relevant molecule in OS development.